# KAZANO

NDC: 64764-337
Generic name: alogliptin and metformin hydrochloride
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20130125

FDA application: NDA203414

## Active ingredients

- ALOGLIPTIN BENZOATE: 12.5 mg/1
- METFORMIN HYDROCHLORIDE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64764-337"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-337
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83cb7914-a683-47bb-a713-f2bc6a596bd2